{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:25Z","timestamp":1786981525318,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s11064-011-0525-z","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T12:33:56Z","timestamp":1307968436000},"page":"2008-2021","source":"Crossref","is-referenced-by-count":14,"title":["Differential Pharmacological Actions of Methadone and Buprenorphine in Human Embryonic Kidney 293 Cells Coexpressing Human \u03bc-Opioid and Opioid Receptor-Like 1 Receptors"],"prefix":"10.1007","volume":"36","author":[{"given":"Cynthia Wei-Sheng","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Wei","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lih-Chu","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Kang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,14]]},"reference":[{"key":"525_CR1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0031-6997(25)06958-3","volume":"48","author":"BN Dhawan","year":"1996","unstructured":"Dhawan BN, Cesselin F, Raghubir R et al (1996) International union of pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567\u2013592","journal-title":"Pharmacol Rev"},{"key":"525_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0163-7258(95)02011-X","volume":"68","author":"M Satoh","year":"1995","unstructured":"Satoh M, Minami M (1995) Molecular pharmacology of the opioid receptors. Pharmacol Ther 68:343\u2013364","journal-title":"Pharmacol Ther"},{"key":"525_CR3","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.2741\/3474","volume":"14","author":"K Alfaras-Melainis","year":"2009","unstructured":"Alfaras-Melainis K, Gomes I, Rozenfeld R et al (2009) Modulation of opioid receptor function by protein\u2013protein interactions. Front Biosci 14:3594\u20133607","journal-title":"Front Biosci"},{"key":"525_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","volume":"341","author":"C Mollereau","year":"1994","unstructured":"Mollereau C, Parmentier M, Mailleux P et al (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341:33\u201338","journal-title":"FEBS Lett"},{"key":"525_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/138945007779315605","volume":"8","author":"LC Chiou","year":"2007","unstructured":"Chiou LC, Liao YY, Fan PC et al (2007) Nociceptin\/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets 8:117\u2013135","journal-title":"Curr Drug Targets"},{"key":"525_CR6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1440-1681.1999.03049.x","volume":"26","author":"M Connor","year":"1999","unstructured":"Connor M, Christie MD (1999) Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 26:493\u2013499","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"525_CR7","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","volume":"258","author":"CJ Evans","year":"1992","unstructured":"Evans CJ, Keith DE Jr, Morrison H et al (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952\u20131955","journal-title":"Science"},{"key":"525_CR8","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.90.21.9954","volume":"90","author":"F Meng","year":"1993","unstructured":"Meng F, Xie GX, Thompson RC et al (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci USA 90:9954\u20139958","journal-title":"Proc Natl Acad Sci USA"},{"key":"525_CR9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0306-4522(94)90570-3","volume":"63","author":"M Tallent","year":"1994","unstructured":"Tallent M, Dichter MA, Bell GI et al (1994) The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells. Neuroscience 63:1033\u20131040","journal-title":"Neuroscience"},{"key":"525_CR10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0026-895X(25)09397-6","volume":"50","author":"ET Piros","year":"1996","unstructured":"Piros ET, Prather PL, Law PY et al (1996) Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors. Mol Pharmacol 50:947\u2013956","journal-title":"Mol Pharmacol"},{"key":"525_CR11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0006-2952(97)00243-8","volume":"54","author":"RJ Spencer","year":"1997","unstructured":"Spencer RJ, Jin W, Thayer SA et al (1997) Mobilization of Ca2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. Biochem Pharmacol 54:809\u2013818","journal-title":"Biochem Pharmacol"},{"key":"525_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-328X(96)00252-5","volume":"45","author":"K Ikeda","year":"1997","unstructured":"Ikeda K, Kobayashi K, Kobayashi T et al (1997) Functional coupling of the nociceptin\/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel. Brain Res Mol Brain Res 45:117\u2013126","journal-title":"Brain Res Mol Brain Res"},{"key":"525_CR13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1996.67031309.x","volume":"67","author":"K Fukuda","year":"1996","unstructured":"Fukuda K, Kato S, Morikawa H et al (1996) Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67:1309\u20131316","journal-title":"J Neurochem"},{"key":"525_CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E (2002) Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710\u2013726","journal-title":"Nat Rev Drug Discov"},{"key":"525_CR15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.yco.0000245759.13997.9d","volume":"19","author":"C Haasen","year":"2006","unstructured":"Haasen C, van den Brink W (2006) Innovations in agonist maintenance treatment of opioid-dependent patients. Curr Opin Psychiatry 19:631\u2013636","journal-title":"Curr Opin Psychiatry"},{"key":"525_CR16","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","volume":"23","author":"K Lutfy","year":"2003","unstructured":"Lutfy K, Eitan S, Bryant CD et al (2003) Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci 23:10331\u201310337","journal-title":"J Neurosci"},{"key":"525_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","volume":"507","author":"T Christoph","year":"2005","unstructured":"Christoph T, Kogel B, Schiene K et al (2005) Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 507:87\u201398","journal-title":"Eur J Pharmacol"},{"key":"525_CR18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","volume":"96","author":"A Dahan","year":"2006","unstructured":"Dahan A, Yassen A, Romberg R et al (2006) Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 96:627\u2013632","journal-title":"Br J Anaesth"},{"key":"525_CR19","first-page":"569","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"HB Gutstein","year":"2001","unstructured":"Gutstein HB, Akil H (2001) Opioid analgesics. In: Goodman LS, Hardman JG, Limbird LE et al (eds) Goodman & Gilman\u2019s the pharmacological basis of therapeutics. McGraw-Hill, Medical Pub. Division, New York, pp 569\u2013619"},{"key":"525_CR20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0196-9781(00)00252-7","volume":"21","author":"P Bloms-Funke","year":"2000","unstructured":"Bloms-Funke P, Gillen C, Schuettler AJ et al (2000) Agonistic effects of the opioid buprenorphine on the nociceptin\/OFQ receptor. Peptides 21:1141\u20131146","journal-title":"Peptides"},{"key":"525_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2004.11.001","volume":"5","author":"F Weiss","year":"2005","unstructured":"Weiss F (2005) Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 5:9\u201319","journal-title":"Curr Opin Pharmacol"},{"key":"525_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","volume":"5","author":"CP Bailey","year":"2005","unstructured":"Bailey CP, Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60\u201368","journal-title":"Curr Opin Pharmacol"},{"key":"525_CR23","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1073\/pnas.74.8.3365","volume":"74","author":"SK Sharma","year":"1977","unstructured":"Sharma SK, Klee WA, Nirenberg M (1977) Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci USA 74:3365\u20133369","journal-title":"Proc Natl Acad Sci USA"},{"key":"525_CR24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/mol.54.6.949","volume":"54","author":"S Chakrabarti","year":"1998","unstructured":"Chakrabarti S, Wang L, Tang WJ et al (1998) Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance\/dependence. Mol Pharmacol 54:949\u2013953","journal-title":"Mol Pharmacol"},{"key":"525_CR25","doi-asserted-by":"crossref","first-page":"21309","DOI":"10.1074\/jbc.271.35.21309","volume":"271","author":"T Avidor-Reiss","year":"1996","unstructured":"Avidor-Reiss T, Nevo I, Levy R et al (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma. J Biol Chem 271:21309\u201321315","journal-title":"J Biol Chem"},{"key":"525_CR26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/1096-9861(20000828)424:3<489::AID-CNE7>3.0.CO;2-O","volume":"424","author":"T Houtani","year":"2000","unstructured":"Houtani T, Nishi M, Takeshima H et al (2000) Distribution of nociceptin\/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice. J Comp Neurol 424:489\u2013508","journal-title":"J Comp Neurol"},{"key":"525_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0006-291X(02)02258-1","volume":"297","author":"YX Pan","year":"2002","unstructured":"Pan YX, Bolan E, Pasternak GW (2002) Dimerization of morphine and orphanin FQ\/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem Biophys Res Commun 297:659\u2013663","journal-title":"Biochem Biophys Res Commun"},{"key":"525_CR28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1471-4159.2004.02921.x","volume":"92","author":"HL Wang","year":"2005","unstructured":"Wang HL, Hsu CY, Huang PC et al (2005) Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist. J Neurochem 92:1285\u20131294","journal-title":"J Neurochem"},{"key":"525_CR29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1074\/jbc.M109.040634","volume":"285","author":"RM Evans","year":"2010","unstructured":"Evans RM, You H, Hameed S et al (2010) Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem 285:1032\u20131040","journal-title":"J Biol Chem"},{"key":"525_CR30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0304-3940(97)00832-X","volume":"237","author":"H Ueda","year":"1997","unstructured":"Ueda H, Yamaguchi T, Tokuyama S et al (1997) Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett 237:136\u2013138","journal-title":"Neurosci Lett"},{"key":"525_CR31","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1523\/JNEUROSCI.20-20-07640.2000","volume":"20","author":"H Ueda","year":"2000","unstructured":"Ueda H, Inoue M, Takeshima H et al (2000) Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 20:7640\u20137647","journal-title":"J Neurosci"},{"key":"525_CR32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.01-0995fje","volume":"16","author":"G Shaw","year":"2002","unstructured":"Shaw G, Morse S, Ararat M et al (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869\u2013871","journal-title":"FASEB J"},{"key":"525_CR33","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1074\/jbc.M008054200","volume":"276","author":"K Chaturvedi","year":"2001","unstructured":"Chaturvedi K, Bandari P, Chinen N et al (2001) Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. J Biol Chem 276:12345\u201312355","journal-title":"J Biol Chem"},{"key":"525_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1087057107313786","volume":"13","author":"S Titus","year":"2008","unstructured":"Titus S, Neumann S, Zheng W et al (2008) Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor. J Biomol Screen 13:120\u2013127","journal-title":"J Biomol Screen"},{"key":"525_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/15406580360545107","volume":"1","author":"D Gabriel","year":"2003","unstructured":"Gabriel D, Vernier M, Pfeifer MJ et al (2003) High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol 1:291\u2013303","journal-title":"Assay Drug Dev Technol"},{"key":"525_CR36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","volume":"399","author":"BA Jordan","year":"1999","unstructured":"Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697\u2013700","journal-title":"Nature"},{"key":"525_CR37","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1073\/pnas.090514397","volume":"97","author":"F Jenck","year":"2000","unstructured":"Jenck F, Wichmann J, Dautzenberg FM et al (2000) A synthetic agonist at the orphanin FQ\/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 97:4938\u20134943","journal-title":"Proc Natl Acad Sci USA"},{"key":"525_CR38","doi-asserted-by":"crossref","first-page":"29732","DOI":"10.1074\/jbc.270.50.29732","volume":"270","author":"T Avidor-Reiss","year":"1995","unstructured":"Avidor-Reiss T, Bayewitch M, Levy R et al (1995) Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270:29732\u201329738","journal-title":"J Biol Chem"},{"key":"525_CR39","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","volume":"20","author":"I Gomes","year":"2000","unstructured":"Gomes I, Jordan BA, Gupta A et al (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110","journal-title":"J Neurosci"},{"key":"525_CR40","doi-asserted-by":"crossref","first-page":"19762","DOI":"10.1074\/jbc.M110373200","volume":"277","author":"M Pfeiffer","year":"2002","unstructured":"Pfeiffer M, Koch T, Schroder H et al (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 277:19762\u201319772","journal-title":"J Biol Chem"},{"key":"525_CR41","doi-asserted-by":"crossref","first-page":"51630","DOI":"10.1074\/jbc.M307095200","volume":"278","author":"M Pfeiffer","year":"2003","unstructured":"Pfeiffer M, Kirscht S, Stumm R et al (2003) Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278:51630\u201351637","journal-title":"J Biol Chem"},{"key":"525_CR42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1254\/jphs.08244FP","volume":"108","author":"M Hojo","year":"2008","unstructured":"Hojo M, Sudo Y, Ando Y et al (2008) mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci 108:308\u2013319","journal-title":"J Pharmacol Sci"},{"key":"525_CR43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuropharm.2008.12.010","volume":"56","author":"H Schroder","year":"2009","unstructured":"Schroder H, Wu DF, Seifert A et al (2009) Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor. Neuropharmacology 56:768\u2013778","journal-title":"Neuropharmacology"},{"key":"525_CR44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/mol.109.055913","volume":"76","author":"W Walwyn","year":"2009","unstructured":"Walwyn W, John S, Maga M et al (2009) Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol 76:134\u2013143","journal-title":"Mol Pharmacol"},{"key":"525_CR45","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1074\/jbc.M500171200","volume":"280","author":"PY Law","year":"2005","unstructured":"Law PY, Erickson-Herbrandson LJ, Zha QQ et al (2005) Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280:11152\u201311164","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"525_CR46","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1038\/sj.bjp.0707490","volume":"153","author":"G Milligan","year":"2008","unstructured":"Milligan G (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol 153(Suppl 1):S216\u2013229","journal-title":"Br J Pharmacol"},{"key":"525_CR47","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1046\/j.1471-4159.1995.65062682.x","volume":"65","author":"JS Chan","year":"1995","unstructured":"Chan JS, Chiu TT, Wong YH (1995) Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. J Neurochem 65:2682\u20132689","journal-title":"J Neurochem"},{"key":"525_CR48","doi-asserted-by":"crossref","first-page":"22772","DOI":"10.1074\/jbc.270.39.22772","volume":"270","author":"S Zhang","year":"1995","unstructured":"Zhang S, Yu L (1995) Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor. J Biol Chem 270:22772\u201322776","journal-title":"J Biol Chem"},{"key":"525_CR49","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(91)90154-4","volume":"48","author":"SR Childers","year":"1991","unstructured":"Childers SR (1991) Opioid receptor-coupled second messenger systems. Life Sci 48:1991\u20132003","journal-title":"Life Sci"},{"key":"525_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01411-8","volume":"340","author":"JC Meunier","year":"1997","unstructured":"Meunier JC (1997) Nociceptin\/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 340:1\u201315","journal-title":"Eur J Pharmacol"},{"key":"525_CR51","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-3565(25)22179-6","volume":"246","author":"RS Duman","year":"1988","unstructured":"Duman RS, Tallman JF, Nestler EJ (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246:1033\u20131039","journal-title":"J Pharmacol Exp Ther"},{"key":"525_CR52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0165-6147(99)01307-3","volume":"20","author":"WF Simonds","year":"1999","unstructured":"Simonds WF (1999) G protein regulation of adenylate cyclase. Trends Pharmacol Sci 20:66\u201373","journal-title":"Trends Pharmacol Sci"},{"key":"525_CR53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/BJ20041670","volume":"386","author":"D Steiner","year":"2005","unstructured":"Steiner D, Avidor-Reiss T, Schallmach E et al (2005) Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi\/o-coupled receptor activation. Biochem J 386:341\u2013348","journal-title":"Biochem J"},{"key":"525_CR54","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0896-6273(93)90213-B","volume":"11","author":"EJ Nestler","year":"1993","unstructured":"Nestler EJ, Hope BT, Widnell KL (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995\u20131006","journal-title":"Neuron"},{"key":"525_CR55","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1097\/00001756-199909290-00005","volume":"10","author":"RY Chan","year":"1999","unstructured":"Chan RY, Wong YH (1999) Chronic activation of ORL1 receptor induces supersensitization of adenylyl cyclase. Neuroreport 10:2901\u20132905","journal-title":"Neuroreport"},{"key":"525_CR56","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1073\/pnas.84.12.4308","volume":"84","author":"A Tempel","year":"1987","unstructured":"Tempel A, Zukin RS (1987) Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci USA 84:4308\u20134312","journal-title":"Proc Natl Acad Sci USA"},{"key":"525_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-5793(94)80603-9","volume":"343","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Kato S, Mori K et al (1994) cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343:42\u201346","journal-title":"FEBS Lett"},{"key":"525_CR58","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.1523\/JNEUROSCI.17-20-07890.1997","volume":"17","author":"SB Lane-Ladd","year":"1997","unstructured":"Lane-Ladd SB, Pineda J, Boundy VA et al (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890\u20137901","journal-title":"J Neurosci"},{"key":"525_CR59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2007.11.021","volume":"63","author":"V Zachariou","year":"2008","unstructured":"Zachariou V, Liu R, LaPlant Q et al (2008) Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry 63:1013\u20131021","journal-title":"Biol Psychiatry"},{"key":"525_CR60","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.4701-05.2006","volume":"26","author":"MH Han","year":"2006","unstructured":"Han MH, Bolanos CA, Green TA et al (2006) Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J Neurosci 26:4624\u20134629","journal-title":"J Neurosci"},{"key":"525_CR61","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1073\/pnas.1010077107","volume":"107","author":"JL Cao","year":"2010","unstructured":"Cao JL, Vialou VF, Lobo MK et al (2010) Essential role of the cAMP\u2013cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons. Proc Natl Acad Sci U S A 107:17011\u201317016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"525_CR62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-4522(96)00338-7","volume":"75","author":"JS Mogil","year":"1996","unstructured":"Mogil JS, Grisel JE, Reinscheid RK et al (1996) Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75:333\u2013337","journal-title":"Neuroscience"},{"key":"525_CR63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuropharm.2005.04.008","volume":"49","author":"JR Shoblock","year":"2005","unstructured":"Shoblock JR, Wichmann J, Maidment NT (2005) The effect of a systemically active ORL-1 agonist, Ro 64\u20136198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology 49:439\u2013446","journal-title":"Neuropharmacology"},{"key":"525_CR64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuropharm.2007.11.003","volume":"54","author":"P Marquez","year":"2008","unstructured":"Marquez P, Nguyen AT, Hamid A et al (2008) The endogenous OFQ\/N\/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology 54:564\u2013568","journal-title":"Neuropharmacology"},{"key":"525_CR65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(03)02081-8","volume":"474","author":"J Kotlinska","year":"2003","unstructured":"Kotlinska J, Rafalski P, Biala G et al (2003) Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur J Pharmacol 474:233\u2013239","journal-title":"Eur J Pharmacol"},{"key":"525_CR66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)23620-5","volume":"248","author":"SJ Heishman","year":"1989","unstructured":"Heishman SJ, Stitzer ML, Bigelow GE et al (1989) Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther 248:127\u2013134","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11064-011-0525-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T23:24:31Z","timestamp":1741217071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0525-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,14]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0525-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,14]]}}}